UPHEALTH, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8402 USD | -5.60% |
|
-9.02% | +266.10% |
| Mar. 21 | UpHealth, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 21 | UpHealth, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 323.1 | 24.54 | 4.245 | 16.59 | - |
| Enterprise Value (EV) 1 | 323.1 | 24.54 | 4.245 | 16.59 | 16.59 |
| P/E ratio | -0.7 x | -0.11 x | -0.07 x | 5.93 x | 2.34 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 2.61 x | 0.15 x | 0.03 x | 0.36 x | 0.33 x |
| EV / Revenue | 2.61 x | 0.15 x | 0.03 x | 0.36 x | 0.33 x |
| EV / EBITDA | -81 x | 7.54 x | 0.22 x | 1.73 x | 1.32 x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | 14,425 | 15,054 | 18,501 | 18,641 | - |
| Reference price 2 | 22.40 | 1.630 | 0.2294 | 0.8900 | 0.8900 |
| Announcement Date | 4/18/22 | 3/2/23 | 3/21/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | 123.8 | 158.8 | 130 | 46.4 | 49.65 |
| EBITDA 1 | -3.99 | 3.256 | 19.56 | 9.565 | 12.54 |
| EBIT 1 | -82.05 | -161.4 | -89.57 | 5.23 | 9.78 |
| Operating Margin | -66.28% | -101.63% | -68.9% | 11.27% | 19.7% |
| Earnings before Tax (EBT) 1 | -342.8 | -232.3 | -57.63 | 2.83 | 7.38 |
| Net income 1 | -341 | -223 | -57.84 | 2.83 | 7.38 |
| Net margin | -275.47% | -140.43% | -44.49% | 6.1% | 14.86% |
| EPS 2 | -31.90 | -15.17 | -3.260 | 0.1500 | 0.3800 |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 4/18/22 | 3/2/23 | 3/21/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 49.07 | 33.9 | 35.97 | 43.67 | 38.67 | 40.5 | 42.14 | 37.82 | 32.68 | 17.35 | 11 | 11.65 | 12 | 11.75 | 11.85 |
| EBITDA 1 | 4.958 | -12.54 | -1.3 | 3.954 | -1.247 | 1.853 | 6.564 | 5.255 | 5.418 | 2.317 | 1.875 | 2.345 | 2.615 | 2.78 | 2.78 |
| EBIT 1 | -2.854 | -39.02 | -17.91 | -10.04 | -120 | -13.41 | -0.778 | -10.74 | -72.79 | -5.263 | 0.6 | 1.04 | 1.78 | 1.81 | 1.81 |
| Operating Margin | -5.82% | -115.09% | -49.79% | -23% | -310.43% | -33.11% | -1.85% | -28.4% | -222.73% | -30.34% | 5.45% | 8.93% | 14.83% | 15.4% | 15.27% |
| Earnings before Tax (EBT) | 39.52 | -338.1 | -20 | -14.7 | -178.8 | -18.82 | -7.635 | -17.75 | -20.14 | -12.11 | - | 0.44 | 1.18 | 1.21 | 1.21 |
| Net income | 32.59 | -336 | -17.44 | -12.44 | -165.8 | -27.36 | -8.083 | -19.13 | -20.6 | -10.02 | - | 0.44 | 1.18 | 1.21 | 1.21 |
| Net margin | 66.42% | -991.15% | -48.5% | -28.48% | -428.7% | -67.55% | -19.18% | -50.57% | -63.05% | -57.78% | - | 3.78% | 9.83% | 10.3% | 10.21% |
| EPS 2 | 2.800 | -23.60 | -1.200 | -0.9000 | -11.17 | -1.820 | -0.5100 | -1.050 | -1.120 | -0.5400 | -0.0800 | 0.005000 | 0.0300 | 0.0300 | 0.0600 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/10/21 | 4/18/22 | 5/23/22 | 8/15/22 | 12/29/22 | 3/2/23 | 5/11/23 | 8/10/23 | 11/20/23 | 3/21/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - |
| Announcement Date | 4/18/22 | 3/2/23 | 3/21/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.89
USD
Average target price
4
USD
Spread / Average Target
+349.44%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +270.37% | 16.59M | |
| +22.91% | 24.31B | |
| -13.07% | 23.88B | |
| +9.94% | 2.63B | |
| -20.45% | 1.91B | |
| +85.85% | 1.86B | |
| -50.22% | 1.51B | |
| +7.97% | 1.36B | |
| -18.38% | 1.25B | |
| +15.94% | 1.13B |
- Stock Market
- Equities
- UPHL Stock
- Financials UpHealth, Inc.
